0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.69%
Revenue growth of 8.69% while 0335.HK is flat. Bruce Berkowitz would check if a small edge can widen further.
27.08%
Gross profit growth of 27.08% while 0335.HK is zero. Bruce Berkowitz would see if minimal improvements could expand further.
-3.63%
Negative EBIT growth while 0335.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-26.39%
Negative operating income growth while 0335.HK is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
3008.70%
Net income growth of 3008.70% while 0335.HK is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
2827.27%
EPS growth of 2827.27% while 0335.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
2827.27%
Diluted EPS growth of 2827.27% while 0335.HK is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
3.02%
Share change of 3.02% while 0335.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.02%
Diluted share change of 3.02% while 0335.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-52.42%
Dividend reduction while 0335.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
2536.42%
OCF growth of 2536.42% while 0335.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
1701.27%
FCF growth of 1701.27% while 0335.HK is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
53271.44%
Positive 10Y revenue/share CAGR while 0335.HK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
189.85%
Positive 5Y CAGR while 0335.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-15.26%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
5898.47%
Positive long-term OCF/share growth while 0335.HK is negative. John Neff would see a structural advantage in sustained cash generation.
2081.08%
5Y OCF/share CAGR above 1.5x 0335.HK's 102.28%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
604.15%
Positive 3Y OCF/share CAGR while 0335.HK is negative. John Neff might see a big short-term edge in operational efficiency.
300.18%
Positive 10Y CAGR while 0335.HK is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-7.74%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-35.85%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
245.28%
Equity/share CAGR of 245.28% while 0335.HK is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-97.11%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-100.00%
Firm’s AR is declining while 0335.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
1.95%
Inventory shrinking or stable vs. 0335.HK's 8.33%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
23.69%
Asset growth above 1.5x 0335.HK's 1.77%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.08%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-35.87%
We’re deleveraging while 0335.HK stands at 7.35%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while 0335.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
34.88%
SG&A growth of 34.88% while 0335.HK is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.